risedronate sodium 35 MG Oral Tablet, 4 Week Pack

RxCUI: 905092
RxNorm name: risedronate sodium 35 MG Oral Tablet, 4 Week Pack
Display name: risedronate sodium 35 MG Oral Tablet, 4 Week Pack
Full name: risedronate sodium 35 MG Oral Tablet, 4 Week Pack
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Risedronate Sodium	RISEDRONATE SODIUM	Teva Pharmaceuticals USA, Inc.	dddcd321-4d2e-4643-bf3c-7b752b33ba39	2026-03-30	Warnings, Adverse reactions	Exact identifier rxcui: 905092
Risedronate Sodium	RISEDRONATE SODIUM	Macleods Pharmaceuticals Limited	62aff8d6-a2f7-4c7e-a102-c70105ac3792	2026-03-01	Warnings, Adverse reactions	Exact identifier rxcui: 905092
risedronate sodium	RISEDRONATE SODIUM	Sun Pharmaceutical Industries, Inc.	e0b5f0ed-ff40-4f0d-bb86-81a7ace9f339	2026-02-17	Warnings, Adverse reactions	Exact identifier rxcui: 905092
Risedronate Sodium	RISEDRONATE SODIUM	Mylan Pharmaceuticals, Inc.	f715718a-407d-4e2a-9834-74a8f1361d03	2026-02-12	Warnings, Adverse reactions	Exact identifier rxcui: 905092
Risedronate Sodium	RISEDRONATE SODIUM	Aurobindo Pharma Limited	89896dfe-f69d-4cb3-bb71-7a7c611071fa	2026-02-11	Warnings, Adverse reactions	Exact identifier rxcui: 905092
Actonel	RISEDRONATE SODIUM	Allergan, Inc.	24ed00e0-25e2-49a8-97fc-66c1b417dc0b	2026-02-04	Warnings, Adverse reactions	Exact identifier rxcui: 905092
Risedronate Sodium	RISEDRONATE SODIUM	Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd	d60a56cb-ef49-4447-9043-7b6879a20d75	2025-12-16	Warnings, Adverse reactions	Exact identifier rxcui: 905092

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 8 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
24ed00e0-25e2-49a8-97fc-66c1b417dc0b	{4 (risedronate sodium 35 MG Oral Tablet) } Pack [GPCK] · risedronate sodium 35 MG (4) Oral Tablet Pack [PSN] · risedronate sodium 35 MG Oral Tablet, 4 Week Pack [SY]	3	31	These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® ( risedronate sodium ) tablets , for oral use Initial U.S. Approval: 199 8	20260204
e0b5f0ed-ff40-4f0d-bb86-81a7ace9f339	{4 (risedronate sodium 35 MG Oral Tablet) } Pack [GPCK] · risedronate sodium 35 MG (4) Oral Tablet Pack [PSN] · risedronate sodium 35 MG Oral Tablet, 4 Week Pack [SY]	3	17	These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 1998	20260217
dddcd321-4d2e-4643-bf3c-7b752b33ba39	{4 (risedronate sodium 35 MG Oral Tablet) } Pack [GPCK] · risedronate sodium 35 MG (4) Oral Tablet Pack [PSN] · risedronate sodium 35 MG Oral Tablet, 4 Week Pack [SY]	3	15	These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for RISEDRONATE SODIUM TABLETS . RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 1998	20260330
d60a56cb-ef49-4447-9043-7b6879a20d75	{4 (risedronate sodium 35 MG Oral Tablet) } Pack [GPCK] · risedronate sodium 35 MG (4) Oral Tablet Pack [PSN] · risedronate sodium 35 MG Oral Tablet, 4 Week Pack [SY]	3	15	These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 1998	20251216
f715718a-407d-4e2a-9834-74a8f1361d03	{4 (risedronate sodium 35 MG Oral Tablet) } Pack [GPCK] · risedronate sodium 35 MG (4) Oral Tablet Pack [PSN] · risedronate sodium 35 MG Oral Tablet, 4 Week Pack [SY]	3	13	These highlights do not include all the information needed to use Risedronate Sodium safely and effectively. See full prescribing information for Risedronate Sodium . Risedronate Sodium tablets , for oral use Initial U.S. Approval: 1998	20260212
62aff8d6-a2f7-4c7e-a102-c70105ac3792	{4 (risedronate sodium 35 MG Oral Tablet) } Pack [GPCK] · risedronate sodium 35 MG (4) Oral Tablet Pack [PSN] · risedronate sodium 35 MG Oral Tablet, 4 Week Pack [SY]	3	9	These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, USP, for oral use Initial U.S. Approval: 1998	20260301
89896dfe-f69d-4cb3-bb71-7a7c611071fa	{4 (risedronate sodium 35 MG Oral Tablet) } Pack [GPCK] · risedronate sodium 35 MG (4) Oral Tablet Pack [PSN] · risedronate sodium 35 MG Oral Tablet, 4 Week Pack [SY]	3	9	These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 1998	20260211
4423d70a-b120-4653-bcf3-0c5ea8b97b0e	{4 (risedronate sodium 35 MG Oral Tablet) } Pack [GPCK] · risedronate sodium 35 MG (4) Oral Tablet Pack [PSN] · risedronate sodium 35 MG Oral Tablet, 4 Week Pack [SY]	3	2	These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® (risedronate sodium) tablets Initial U.S. Approval: 1998	20100324